Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/06/1996 | WO1996027004A1 An immortalized mammal hybridoma fusion partner |
09/06/1996 | WO1996027002A1 Novel lipase gene and process for the production of lipase with the use of the same |
09/06/1996 | WO1996026964A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
09/06/1996 | WO1996026963A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
09/06/1996 | WO1996026962A1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
09/06/1996 | WO1996026960A1 Fish basic fibroblast growth factor, dna and use of the same |
09/06/1996 | WO1996026959A1 Human transcription factors and binding assays |
09/06/1996 | WO1996026952A1 Multiple drug resistance gene of aspergillus flavus |
09/06/1996 | WO1996026951A1 Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
09/06/1996 | WO1996026745A1 Biosynthetic virus vectors for gene therapy |
09/06/1996 | WO1996026742A1 Gene transfer-mediated angiogenesis therapy |
09/06/1996 | WO1996026737A1 Morphogen-induced dentine regeneration |
09/06/1996 | WO1996026736A1 Vascular endothelial growth factor-b |
09/06/1996 | WO1996026733A1 Codominance-mediated toxins |
09/06/1996 | WO1996026639A1 Cotton modification using ovary-tissue transcriptional factors |
09/06/1996 | WO1996021728A3 Transgenic animals having a defective thyroid hormone receptor gene |
09/06/1996 | WO1996021470A3 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
09/06/1996 | WO1996021036A3 Nucleic acid condensing agents with reduced immunogenicity |
09/06/1996 | WO1996021035A3 Retroviral delivery of full length factor VIII |
09/06/1996 | WO1996021015A3 Combination gene delivery vehicles |
09/06/1996 | WO1996021007A3 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
09/06/1996 | WO1996020688A3 Triggered pore-forming agents |
09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
09/06/1996 | WO1996019568A3 Stabilized ribozyme analogs |
09/06/1996 | WO1996018372A3 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
09/06/1996 | WO1996017934A3 Cloning and recombinant production of crf receptor(s) |
09/06/1996 | WO1996015239A3 Isoflavone reductase promoter |
09/06/1996 | WO1996012804A3 Recombinant dna |
09/06/1996 | CA2217186A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
09/06/1996 | CA2214341A1 Morphogen-induced dentine regeneration |
09/06/1996 | CA2213857A1 A method for expressing modified recombinant proteins in a bacterial system |
09/06/1996 | CA2213734A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
09/06/1996 | CA2213669A1 Transgenic animals as model of psoriasis |
09/06/1996 | CA2213622A1 Detection of biomolecules |
09/06/1996 | CA2211788A1 Multiple drug resistance gene of aspergillus flavus |
09/06/1996 | CA2211682A1 Multiple drug resistance gene of aspergillus fumigatus |
09/06/1996 | CA2188575A1 Gene transfer-mediated angiogenesis therapy |
09/06/1996 | CA2188571A1 Process for preparing doxorubicin |
09/04/1996 | EP0730030A1 Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
09/04/1996 | EP0730029A2 Actinoplanes sp. biosynthetic pathway genes for acarbose, isolation and use |
09/04/1996 | EP0730028A1 Novel cholesterol oxidase |
09/04/1996 | EP0729975A1 Ecdn protein and dna coding for the same |
09/04/1996 | EP0729580A1 Method of identifying hdm-2-specific antibodies |
09/04/1996 | EP0729518A1 Primers and probes for the amplification and detection of cmv nucleic acid |
09/04/1996 | EP0729516A1 Recombinant adenoviruses for gene therapy in cancers |
09/04/1996 | EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
09/04/1996 | EP0729514A1 Chimeric regulatory regions and gene cassettes for expression of genes in plants |
09/04/1996 | EP0729513A1 Analog of haemophilus hin47 with reduced protease activity |
09/04/1996 | EP0729512A1 Dna, dna constructs, cells and plants derived therefrom |
09/04/1996 | EP0729511A1 Compositions and methods for utilizing conditionally lethal genes |
09/04/1996 | EP0729510A1 Method for detecting charged oligonucleotides in biological fluids |
09/04/1996 | EP0729509A1 Vaccine against mumps containing a jeryl-lynn virus strain |
09/04/1996 | EP0729506A1 Myocardial grafts and cellular compositions useful for same |
09/04/1996 | EP0729505A1 Method of producing recombinant dimeric enzyme |
09/04/1996 | EP0729474A1 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages |
09/04/1996 | EP0729361A1 Method of treating neurological disorders |
09/04/1996 | EP0729325A1 Osteogenic product and process |
09/04/1996 | EP0729300A1 Novel fas protein and methods of use thereof |
09/04/1996 | EP0643776B1 Nucleotidique sequences obtained from genes coding pectate-lyases, and utilizations thereof particularly for the detection of bacteria of the genus erwinia |
09/04/1996 | EP0630384A4 Methods and compounds for prevention of graft rejection. |
09/04/1996 | EP0560932B1 Methods and compositions for the suppression of neu mediated transformation |
09/04/1996 | EP0528827B1 Protein partner screening assays and uses thereof |
09/04/1996 | EP0506884B1 Method of delivering molecules into eukaryotic cells |
09/04/1996 | EP0477220B1 Methods for tagging and tracing materials with nucleic acids |
09/04/1996 | EP0463115B1 Acetylated heterologous polypeptides |
09/04/1996 | EP0420911B1 Gene therapy using gene fusions for genetic or acquired disorders |
09/04/1996 | EP0371119B1 Retroviral vector |
09/04/1996 | CN1130406A Monoclonal antibody that recognizes interstitial cell surface antigen |
09/04/1996 | CN1130405A Monoclonal antibody that induces apoptosis |
09/04/1996 | CN1130402A Pro-urokinase mutants |
09/04/1996 | CN1130401A Regulated apoptosis |
09/04/1996 | CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use |
09/03/1996 | US5552541 Haptenic probes for detecting capture polynucleotides |
09/03/1996 | US5552538 Oligonucleotides with cleavable sites |
09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
09/03/1996 | US5552535 Multiple oligonucleotide containing oligomers and the cleanable linkers used in their preparation |
09/03/1996 | US5552527 Genetic engineering method for increasing resistance to plant diseases |
09/03/1996 | US5552471 Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides |
09/03/1996 | US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
09/03/1996 | US5552390 Phosphorothioate inhibitors of metastatic breast cancer |
09/03/1996 | US5552381 Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity |
09/03/1996 | US5552314 Cloning dna using genetic engineering in host cells |
09/03/1996 | US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy |
09/03/1996 | US5552309 Use of polyols for improving the introduction of genetic material into cells |
09/03/1996 | US5552308 CDNA clone of a rat serotonin transporter and protein encoded thereby |
09/03/1996 | US5552306 Isolated nucleic acid encoding cyanobacterial d6-desaturase |
09/03/1996 | US5552304 Polypeptide plasmid vectors for dna sequences |
09/03/1996 | US5552302 Gene expression with cloning of genes for enzyme inhibitors |
09/03/1996 | US5552301 Process for enchancing the production of heterologous protein in biologically active conformation in a transformed E. coli dnaK mutant host cell |
09/03/1996 | US5552300 T cell antigen receptor V region proteins and methods of preparation thereof |
09/03/1996 | US5552299 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptides |
09/03/1996 | US5552293 Tumor antigen specific antibody |
09/03/1996 | US5552289 cDNA encoding the long isoform of the D2 dopamine receptor |
09/03/1996 | US5552287 Monoclonal antibody specific for antigens in mouse inbred strains |
09/03/1996 | US5552286 Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
09/03/1996 | US5552284 Detection of interleukin-8 receptors by nudeic acid hybridization |
09/03/1996 | US5552283 Method, reagents and kit for diagnosis and targeted screening for P53 mutations |